Arizona is the first state to enact a law to allow drug companies to communicate off-label uses of their products. A conservative think tank is hoping other states will follow suit.
The Free Speech in Medicine Act (H.B. 2382), signed March 21 by Arizona Gov. Doug Ducey (R), allows drug companies to communicate with doctors and other health-care providers about safe and effective off-label uses for approved medical products. But it doesn’t permit manufacturers to advertise off-label uses directly to the public.
The legislation was drafted by the Goldwater Institute, a Phoenix-based think tank that advocates for limited ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.